Panellists from Novartis, ICON PLC, and Astellas Pharma explored the ethical implications of AI use in clinical trials, paying attention to emerging risks, key considerations, and future trends. If you missed the discussion, we’re pleased to share our top 10 takeaways from this collaborative discussion. From the importance of transparency in AI systems to the necessity of robust data frameworks, download the infographic to discover how leading pharma organisations are innovating their clinical trials with AI efficiently and safely.